Epstein Secrets

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

Bruce Klein Klaus Kleinfeld Mark Kleinman Andrzej Klesyk Hans Klingenberg Jurgen Kluge Steffen Klusmann Hermann-Josef Knipper Carsten Knop Nigel Knowles Yoshimitsu Kobayashi Eizo Kobayashi Aaron Koblin Caio Koch-Weser Chanda Kochhar Nancy Koehn Sergey A. Kogogin Annie Koh Manuel Kohnstamm Y

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

ann-Josef Knipper Deputy Editor-in-Chief Handelsblatt Germany Carsten Knop Senior Business Editor Frankfurter Allgemeine Germany Zeitung Sir Nigel Knowles Managing Partner DLA Piper UK LLP United Kingdom Eizo Kobayashi Chairman and Representative Itochu Corporation Japan Director Yoshimitsu Kob

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

ann-Josef Knipper Deputy Editor-in-Chief Handelsblatt Germany Carsten Knop Senior Business Editor Frankfurter Allgemeine Germany Zeitung Sir Nigel Knowles Managing Partner DLA Piper UK LLP United Kingdom Eizo Kobayashi Chairman and Representative Itochu Corporation Japan Director Yoshimitsu Kob

John K. Defterios John J. DeGioia Alain Dehaze Jeffrey Deitch Marijn E. Dekkers Michael S. Dell Chris

oth Katherine Klein Klaus Kleinfeld Andrzej Klesyk Hans Klingenberg Lutz Knappmann John Knight Edward S. Knight Carsten Knop Klaas Knot Sir Nigel Knowles Teresa Ko Tomas Ko Freitag de Lara Chief Executive Officer and Executive Vice-Chairman Group General Manager; Country Head, India: Director C